Drug Trial Radar · NCT01233050
Efficacy Comparison of Two Preoperative Skin Antisepsis Preparations in Colorectal Surgery
Last checked: Nov 20, 2026Latest source record: Jul 18, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
802
Actual
Start
Dec 2010
Primary completion
Feb 2015
Study completion Feb 2015
Sponsor
- Lead sponsor
- University of PennsylvaniaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- 3M
- First posted
- Nov 2, 2010
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Surgical site infections (SSI) are one of the most common complications in the post-operative patient, and the second most common health care associated infection overall. It is estimated that there are between 500 thousand and 1.1 million surgical site infections in the United States each year. Given the magnitude of the problem, prevention of surgical site infections is a major goal of peri-operative care. However, skin preparation prior to surgery has not been as rigorously examined. The primary objective of this study is to compare the efficacy of two FDA approved, popular peri-operative skin preparations 2% chlorhexidine gluconate / 70% isopropyl alcohol to Iodine Povacrylex \[0.7% available Iodine\] / 74% Isopropyl Alcohol in the prevention of superficial surgical site infection. Male and female patients, age 18 years and older undergoing elective colorectal surgical procedures involving a laparotomy will be enrolled. These patients are at high risk of SSI. Eligible patients will be assessed at regular intervals for SSI and characterization of bacterial pathogen(s) in patients with SSI. Patients will remain enrolled into the study until 35 days postoperatively.
Conditions
- Colorectal Surgery
Interventions
2% Chlorhexidine Gluconate/70% Isopropyl AlcoholDrug
Preoperative skin antisepsis preparation
Iodine Povacrylex/74% Isopropyl AlcoholDrug
preoperative skin antisepsis preparation
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Primary Objective Measures the Proportion of Patients With Superficial Site Infection as Defined by the CDC.Time frame: within 35 days of randomization to treatment assignment
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
Pennsylvania Hospital
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.